Monitor the vote results for the equity incentive plan increase, as approval could lead to share dilution. The other proposals are standard governance items unlikely to impact operations.
Price Chart
Executive Summary
Atara Biotherapeutics is holding its 2026 annual meeting to vote on four key proposals: electing two directors, approving executive compensation, increasing shares in its equity incentive plan by 400,000, and ratifying Deloitte & Touche as its auditor. The filing is a routine proxy statement from management.
Key Facts
- Annual meeting to vote on director elections, executive compensation, equity plan increase, and auditor ratification
- Management is soliciting votes for all proposals
- No activist involvement or contested board seats
- Routine annual corporate governance matters
Financial Impact
400,000 additional shares authorized in equity incentive plan
Risk Factors
- Potential share dilution from the equity plan increase
- Shareholder opposition to executive compensation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177280 |
| Document: 0001193125-26-177280-index-headers.html | 0001193125-26-177280 |
| Document: 0001193125-26-177280-index.html | 0001193125-26-177280 |
| Document: 0001193125-26-177280.txt | 0001193125-26-177280 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 26, 2026 14w ago | 8-K | $11.17 $8.93 | ▼ −20.05% | ▼ −24.44% | $9.48 (−15.13%) |
Jun 15, 2026 15w ago | 3 | $9.62 $9.89 | ▲ +2.81% | ▲ +1.81% | $9.48 (−1.46%) |
May 7, 2026 21w ago | 8-K | $9.93 $8.55 | ▼ −13.90% | ▼ −17.73% | $9.48 (−4.53%) |
May 7, 2026 21w ago | Insider Cluster | $9.93 $8.55 | ▼ −13.90% | ▼ −17.73% | $9.48 (−4.53%) |
Apr 24, 2026 23w ago | DEFA14A | $4.99 $8.13 | ▲ +62.83% | ▲ +58.05% | $9.48 (+89.98%) |
Mar 17, 2026 28w ago | S-3 | $5.00 $10.46 | ▲ +109.20% | ▲ +97.67% | $9.48 (+89.60%) |
Mar 12, 2026 29w ago | 8-K | $6.90 $9.92 | ▲ +43.77% | ▲ +33.07% | $9.48 (+37.39%) |
Mar 3, 2026 30w ago | 8-K | $5.42 $10.54 | ▲ +94.46% | ▲ +84.15% | $9.48 (+74.91%) |
Mar 2, 2026 30w ago | Insider Cluster | $4.91 $9.61 | ▲ +95.72% | ▲ +86.40% | $9.48 (+93.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access